|
CAB39 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.187600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.762200E-01 |
| Normal-vs-Stage2 |
8.810800E-01 |
| Normal-vs-Stage3 |
4.172000E-02 |
| Normal-vs-Stage4 |
4.317900E-03 |
| Stage1-vs-Stage2 |
5.138800E-01 |
| Stage1-vs-Stage3 |
4.502100E-03 |
| Stage1-vs-Stage4 |
4.168500E-04 |
| Stage2-vs-Stage3 |
1.911810E-01 |
| Stage2-vs-Stage4 |
4.318500E-02 |
| Stage3-vs-Stage4 |
3.362600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.209200E-01 |
| Normal-vs-AfricanAmerican |
8.971400E-01 |
| Normal-vs-Asian |
4.058000E-01 |
| Caucasian-vs-AfricanAmerican |
6.267000E-01 |
| Caucasian-vs-Asian |
1.490160E-01 |
| AfricanAmerican-vs-Asian |
6.413600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.075200E-01 |
| Normal-vs-Female |
6.945800E-01 |
| Male-vs-Female |
8.022400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.800800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.237000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.792200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.269000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.125600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.939600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.689400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.852800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.676600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.649800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.699400E-03 |
| Classical-VS-Follicular |
9.805500E-02 |
| Classical-VS-Other |
4.490200E-01 |
| Classical-VS-Normal |
4.512800E-01 |
| Tall-VS-Follicular |
1.276180E-01 |
| Tall-VS-Other |
4.751200E-01 |
| Tall-VS-Normal |
1.126070E-02 |
| Follicular-VS-Other |
8.567200E-01 |
| Follicular-VS-Normal |
3.503600E-01 |
| Other-VS-Normal |
5.819600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.283000E-01 |
| Normal-vs-N1 |
2.400000E-02 |
| N0-vs-N1 |
6.791600E-02 |
|
|
